The company’s revenue from operations declined 20.3% year-on-year to ₹310.6 crore, down from ₹389.5 crore in the ...

Deven Choksey recommended Accumulate rating on Cyient DLM with a target price of Rs 483 in its research report dated October ...

Motilal Oswal is bullish on Cyient DLM has recommended buy rating on the stock with a target price of Rs 550 in its research ...

Cyient DLM and Tata Consultancy Services are under the brokerage lens today following key updates. Analysts have maintained ...

Cyient DLM reported a 113.3% YoY jump in Q2 FY26 net profit to Rs 32 crore, despite a 20.3% decline in revenue to Rs 310.6 ...

Motilal Oswal recommends buying Persistent Systems, Tech Mahindra, and Cyient DLM for up to 29% upside; check targets and analysis now.

Cyient DLM’s Q2 FY26 consolidated revenue/Ebitda declined ~20%/1% YoY to Rs 3.1 billion/Rs 312 million. However, Ebitda ...

Despite geopolitical headwinds, Cyient DLM Ltd (BOM:543933) showcases robust financial health and strategic wins in key sectors.

DLM Capital Group Limited is targeting to raise up to N10 billion from the issuance of Series 2(Tranche A and Tranche B) ...

DLM Capital Group successfully issued N9 billion Series 1 Sovereign Bond Backed Composite Notes under its N30 billion Medium-Term Note ...

DLM Capital Group, a leading Nigerian development investment bank, has launched a N10 billion Series 2 Commercial Paper (CP) under ...

Figure 1: DAI (DLM-1/ZBP1) is a positive regulator for type I IFN induction by cytosolic DNA. Figure 2: DAI (DLM-1/ZBP1) is critical for B-DNA-mediated IRF3 activation and Ifnb mRNA expression. Figure ...